Based on these immunological features, our screening strategy defined major criteria as dysgammaglobulinemia, decreased CD19+ B cells/decreased CD19+CD27+IgM-IgD- cells, an inverted CD4+/CD8+ T cell ratio, and increased CD8+CD45RA+CD27+ cells. Here, CD19 is linked to dysgammaglobulinemia.